ライフサイエンスコーパス: myelin-associated glycoprotein

1 igodendrocyte-myelin glycoprotein), and MAG (myelin-associated glycoprotein).

2 ant proteins but also brain proteins such as myelin associated glycoprotein.

3 eled fatty acid and immunostaining of P0 and myelin associated glycoprotein.

4 in the growth cone induced by the repellent myelin-associated glycoprotein.

5 drocyte apoptosis and a preferential loss of myelin-associated glycoprotein.

6 vation and neurite inhibition in response to myelin-associated glycoprotein.

7 wth and overcame growth inhibition caused by myelin-associated glycoprotein.

8 PP1 mediate growth cone repulsion induced by myelin-associated glycoprotein.

9 In line with these data, myelin-associated glycoprotein addition to cerebellar gr

10 go, oligodendrocyte-myelin glycoprotein, and myelin-associated glycoprotein, all bind to an axonal No

11 glecs were known, namely sialoadhesin, CD22, myelin-associated glycoprotein and CD33.

12 ditions, but also promotes neurite growth on myelin-associated glycoprotein and chondroitin sulfate p

13 Myelin-associated glycoprotein and chondroitin sulfate p

14 ing of neuronal growth cones to netrin-1 and myelin-associated glycoprotein and for netrin-1/DCC-depe

15 Immunofluorescence labeling for myelin-associated glycoprotein and for the protein Caspr

16 However, myelin-associated glycoprotein and semaphorin 3A regulat

17 inding of the myelin inhibitors Nogo-A, MAG (myelin-associated glycoprotein), and OMgp (oligodendrocy

18 Three myelin proteins, Nogo, MAG (myelin-associated glycoprotein), and OMgp (oligodendrocy

19 (sialoadhesin), siglec-3 (CD33), siglec-4a (myelin-associated glycoprotein), and siglec-5 to alpha2-

20 ntified constituents of this activity (Nogo, myelin-associated glycoprotein, and oligodendrocyte myel

21 iated, structurally distinct proteins, Nogo, myelin-associated glycoprotein, and oligodendrocyte myel

22 nervous system (CNS) myelin proteins, Nogo, myelin-associated glycoprotein, and oligodendrocyte myel

23 The 7E11 monoclonal antibody blocks Nogo, myelin-associated glycoprotein, and oligodendrocyte myel

24 t or second Ig domains of the I-type lectins myelin-associated glycoprotein, and sialoadhesin did not

25 her known Siglec family members (CD22, CD33, myelin-associated glycoprotein, and sialoadhesin) show t

26 valuated Ig gene usage in patients with anti-myelin-associated glycoprotein (anti-MAG) neuropathy, an

27 usion body myositis and paraproteinemic anti-myelin-associated glycoprotein antibody demyelinating po

28 pain substrates [myelin basic protein (MBP); myelin-associated glycoprotein] are degraded in this dis

29 S-100 antigen as a pan-Schwann cell marker, myelin-associated glycoprotein as a marker for myelinati

30 Myelin-associated glycoprotein binds to LRP1 with high a

31 rin-1, brain-derived neurotrophic factor and myelin-associated glycoprotein, but not to semaphorin 3A

32 action and stabilization of oligodendrocytic myelin-associated glycoprotein by neuronal gangliosides

33 at cleaves one class of axonal receptors for myelin-associated glycoprotein, enhances spinal axon out

34 ets for autoantibodies include gangliosides, myelin associated glycoprotein, Hu antigen and extractab

35 Moreover, the GPR12-mediated rescue from myelin-associated glycoprotein inhibition was attributab

36 elin basic protein and protein zero, whereas myelin-associated glycoprotein is largely unaffected.

37 This shortened induction was also found in myelin-associated glycoprotein knock-out mice, but not i

38 ys revealed that C1q interacts directly with myelin associated glycoprotein (MAG) in myelin, resultin

39 axon growth on the nonpermissive substrates myelin-associated glycoprotein (MAG) and chondroitin sul

40 binds the myelin inhibitors NogoA, OMgp, and myelin-associated glycoprotein (MAG) and has been propos

41 racted to affect expression of genes such as myelin-associated glycoprotein (Mag) and myelin basic pr

42 In addition to myelin-associated glycoprotein (MAG) and Nogo-A, availab

43 The neural sialoadhesins, myelin-associated glycoprotein (MAG) and Schwann cell my

44 We have analyzed mice that lack both the myelin-associated glycoprotein (MAG) and the myelin gala

45 We subsequently identified myelin-associated glycoprotein (MAG) as a cross-reactive

46 roteins including neurofascin155 (NF155) and myelin-associated glycoprotein (MAG) at axo-glial juncti

47 Myelin-associated glycoprotein (MAG) binds to the nerve

48 brain-derived neurotrophic factor (BDNF), or myelin-associated glycoprotein (MAG) but not by a gradie

49 hmidt-Lantermann (S-L) incisures contain the myelin-associated glycoprotein (MAG) but not P(0) or pro

50 ealed a 9 mum dissociation constant for PirB-myelin-associated glycoprotein (MAG) ectodomain interact

51 nel of myelin antibodies, we discovered that myelin-associated glycoprotein (MAG) expression is drama

52 trates that mice with a null mutation of the myelin-associated glycoprotein (MAG) gene have a chronic

53 Sox10 synergy, including a novel site in the Myelin-associated glycoprotein (Mag) gene, is also reduc

54 Myelin-associated glycoprotein (MAG) has been implicated

55 I(3,5)P2 deficiency leads to accumulation of myelin-associated glycoprotein (MAG) in LAMP1(+)perinucl

56 Immunocytochemical detection of myelin-associated glycoprotein (MAG) indicated that Schw

57 The myelin-associated glycoprotein (MAG) is a member of the

58 Myelin-associated glycoprotein (MAG) is a potent inhibit

59 Myelin-associated glycoprotein (MAG) is a sialic acid-bi

60 Myelin-associated glycoprotein (MAG) is a transmembrane

61 Myelin-associated glycoprotein (MAG) is an abundant myel

62 Myelin-associated glycoprotein (MAG) is expressed in per

63 Myelin-associated glycoprotein (MAG) is susceptible to p

64 myelination, myelin basic protein (MBP) and myelin-associated glycoprotein (MAG) myelin proteins wer

65 n GD1a and GT1b gangliosides on the axon and myelin-associated glycoprotein (MAG) on myelin.

66 In the injured nervous system, myelin-associated glycoprotein (MAG) on residual myelin

67 n was enhanced, and the repulsion induced by myelin-associated glycoprotein (MAG) or myelin membrane

68 dhesion molecules neurofascin155 (NF155) and myelin-associated glycoprotein (MAG) require membrane mi

69 godendrocyte myelin glycoprotein (OMgp), and myelin-associated glycoprotein (MAG) to mediate neurite

70 ic protein (MBP), proteolipid protein (PLP), myelin-associated glycoprotein (MAG), "Rip," and the neu

71 crease in calpain content and degradation of myelin-associated glycoprotein (MAG), a calpain substrat

72 Myelin-associated glycoprotein (MAG), a membrane-bound p

73 e reported in mice with a disrupted gene for myelin-associated glycoprotein (MAG), a myelin receptor

74 Myelin-associated glycoprotein (MAG), a nervous system c

75 Myelin-associated glycoprotein (MAG), a sialic acid bind

76 We now demonstrate that myelin-associated glycoprotein (MAG), a well known inhib

77 Myelin-associated glycoprotein (MAG), an inhibitor of ax

78 Antibodies to P0, myelin-associated glycoprotein (MAG), and neural cell ad

79 und along axons: myelin basic protein (MBP), myelin-associated glycoprotein (MAG), and neuron-glia ce

80 the myelin inhibitory proteins Nogo/Nogo-66, myelin-associated glycoprotein (MAG), and oligodendrocyt

81 '-cyclic nucleotide phosphodiesterase (CNP), myelin-associated glycoprotein (MAG), and P0.

82 mutants, is defective for the expression of myelin-associated glycoprotein (MAG), and the misregulat

83 xonal receptors, Cadm2 and Cadm3, as well as myelin-associated glycoprotein (MAG), are enriched at th

84 One inhibitor, myelin-associated glycoprotein (MAG), binds to sialoglyc

85 growth cone turning induced by a gradient of myelin-associated glycoprotein (MAG), cAMP acts by modul

86 igodendrocyte myelin glycoprotein (OMgp) and myelin-associated glycoprotein (MAG), exert their effect

87 For example, the endogenous lectin, myelin-associated glycoprotein (MAG), is reported to bin

88 One glial molecule, the myelin-associated glycoprotein (MAG), located in the ada

89 , internode-forming morphology co-expressing myelin-associated glycoprotein (MAG), necessary for axon

90 part to myelin-associated inhibitors such as myelin-associated glycoprotein (MAG), Nogo-A, and oligod

91 nhibitors of regeneration in myelin, such as myelin-associated glycoprotein (MAG), play an important

92 olecules associated with CNS myelin, such as myelin-associated glycoprotein (MAG), represent major ob

93 obulin-like family member lectins (siglecs), myelin-associated glycoprotein (MAG), Schwann cell myeli

94 general and by a specific myelin component, myelin-associated glycoprotein (MAG), than in the same t

95 lated expression of splice variants encoding myelin-associated glycoprotein (MAG), which generates tw

96 eurofascin and NrCAM at sites independent of myelin-associated glycoprotein (MAG)-staining Schwann ce

97 igodendrocytes and oligodendrocyte- derived, myelin-associated glycoprotein (MAG).

98 part, via the cell-surface adhesion protein, myelin-associated glycoprotein (MAG).

99 g junctional adhesion molecule-C (JAM-C) and myelin-associated glycoprotein (MAG).

100 ed by inhibitory proteins in myelin, such as myelin-associated glycoprotein (MAG).

101 n receptors during chemorepulsion induced by myelin-associated glycoprotein (MAG).

102 d responsiveness to neurotrophin 3 (NT3) and myelin-associated glycoprotein (MAG).

103 ssociated inhibitors of regeneration such as myelin-associated glycoprotein (MAG).

104 owth cone chemotaxis, including netrin-1 and myelin-associated glycoprotein (MAG).

105 limited by two proteins in myelin, Nogo and myelin-associated glycoprotein (MAG).

106 Myelin-associated glycoprotein (MAG, Siglec-4) is one of

107 nhibitory cytokines (TNFalpha, IL-1beta) and myelin-associated glycoproteins (MAG, Nogo).

108 pathies, such as Guillain-Barre syndrome and myelin-associated glycoprotein neuropathy (MAG), are cau

109 Anti-MAG (myelin-associated glycoprotein) neuropathy is a disablin

110 ARIs include myelin-associated glycoprotein, Nogo, oligodendrocyte-my

111 We show that myelin-associated glycoprotein or CNS myelin, in general

112 g molecules--such as myelin-derived Nogo and myelin-associated glycoprotein--or reactive astrocyte-pr

113 ite matter and preferentially became Olig2+, Myelin Associated Glycoprotein-positive, Myelin Basic Pr

114 Others showed that siglec-4a (myelin-associated glycoprotein) prefers Neu5Ac over Neu5

115 ELISAs were used to measure the myelin-associated glycoprotein:proteolipid protein-1 rat

116 Instead, myelin-associated glycoprotein recruited p75 neurotrophi

117 erized siglecs, sialoadhesin, CD22, CD33 and myelin-associated glycoprotein, several new ones, siglec

118 Most remarkable was the finding that myelin-associated glycoprotein (Siglec-4) binds with 500

119 ctions of hypoxia-inducible factors, and the myelin associated glycoprotein to proteolipid protein 1

120 amined the relationship between the ratio of myelin-associated glycoprotein to proteolipid protein 1

121 We previously showed the ratio of myelin-associated glycoprotein to proteolipid protein 1

122 th factor in the context of reduced ratio of myelin-associated glycoprotein to proteolipid protein 1

123 ignificant correlations between the ratio of myelin-associated glycoprotein to proteolipid protein 1

124 matter perfusion, indicated by the ratio of myelin-associated glycoprotein to proteolipid protein 1,

125 Collapsin-1/Semaphorin III/D (Sema III) and myelin-associated glycoprotein trigger repulsive turning

126 Expression of myelin-associated glycoprotein was also decreased by abo

127 The myelin-associated glycoprotein was appropriately sorted

128 in, myelin oligodendrocyte glycoprotein, and myelin-associated glycoprotein, was delayed in the spina

129 by 206.5% while the levels of 68 kDa NFP and myelin-associated glycoprotein were decreased by 42.9 an

130 n overcame neurite outgrowth inhibition from myelin-associated glycoprotein, which was mirrored by ac

131 Indeed, there is an early loss of myelin-associated glycoprotein within the lesion, despit

132 ing of beta1-integrin adhesions triggered by myelin-associated glycoprotein, yet permitted integrin c